Albrecht Franke, Deceased

Title: Albrecht Franke: A Legacy of Innovation in Antiarrhythmic Agents

Introduction

Albrecht Franke was a notable inventor whose contributions to the field of pharmaceuticals have left a lasting impact. He was based in Wachenheim, Germany, and held a total of 3 patents during his career. His work primarily focused on developing effective antiarrhythmic agents, showcasing his dedication to advancing medical science.

Latest Patents

Franke's latest patents include significant innovations such as "Tetracyclic quinazoline derivatives, effective as antiarrhythmic agents." This patent describes a tetracyclic quinazoline derivative with a specific formula, which demonstrates effectiveness in treating arrhythmias. Another notable patent involves "Therapeutic agents containing enantiomers of propafenone," which details the preparation and application of these agents for specific patient groups. These inventions highlight his commitment to improving therapeutic options for patients with heart conditions.

Career Highlights

Throughout his career, Albrecht Franke worked with Basf Aktiengesellschaft, a leading chemical company known for its innovative research and development. His work at Basf allowed him to collaborate with other talented professionals and contribute to groundbreaking advancements in the pharmaceutical industry.

Collaborations

Franke collaborated with esteemed colleagues such as Rainer Schlecker and Gerda Von Philipsborn. Their combined efforts in research and development further enhanced the quality and effectiveness of the therapeutic agents they created.

Conclusion

Albrecht Franke's contributions to the field of antiarrhythmic agents have made a significant impact on medical science. His innovative patents and collaborations with other professionals reflect his dedication to improving patient care. His legacy continues to inspire future generations of inventors and researchers in the pharmaceutical industry.